Facial Masking for Covid-19 - Potential for "Variolation" as We Await a Vaccine

N Engl J Med. 2020 Oct 29;383(18):e101. doi: 10.1056/NEJMp2026913. Epub 2020 Sep 8.

Authors

Monica Gandhi¹, George W Rutherford¹

Affiliation

¹ From the Center for AIDS Research, Division of HIV, Infectious Diseases, and Global Medicine, Department of Medicine (M.G.), and the Division of Infectious Disease and Global Epidemiology, Department of Epidemiology and Biostatistics (G.W.R.), University of California, San Francisco, San Francisco.

No abstract available

MeSH terms

Asymptomatic Infections
Betacoronavirus
COVID-19
Communicable Disease Control / methods*
Coronavirus Infections / prevention & control*
Humans
Immunity, Cellular
Immunization
Masks*
Pandemics / prevention & control*
Pneumonia, Viral / prevention & control*
SARS-CoV-2

Grants and funding

R01 AI158013/AI/NIAID NIH HHS/United States